TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17545068

Group type: EXPERIMENTAL
Intervention: Emotional Stroop task
Number of subjects: 13
Study: 15675977

Group type: EXPERIMENTAL
Intervention: Propofol changed to desflurane
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isoflurane changed to desflurane
Number of subjects: 42
Study: 11908712

Group type: EXPERIMENTAL
Intervention: ACOP+ (cyclophosphamide, doxorubicin, vincristine, 6-mercaptopurine, and prednisone)
Number of subjects: 120

Group type: COMPARATOR
Intervention: APO (doxorubicin, vincristine, 6-mercaptopurine, and prednisone)
Number of subjects: 120
Study: 9793671

Group type: EXPERIMENTAL
Intervention: Cisatracurium, 0.20 mg.kg‐1 (4 x ED95)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cisatracurium, 0.30 mg.kg‐1 (6 x ED95)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vecuronium, 0.30 mg.kg‐1 (6 x ED95)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cisatracurium, 0.40 mg.kg‐1 (8 x ED95)
Number of subjects: 100
Study: 7541158

Group type: EXPERIMENTAL
Intervention: Carboplatin plus paclitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin plus paclitaxel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 0
Study: 2565210

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg twice daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Amiloride (5 mg daily)
Number of subjects: 8
Study: 336056

Group type: EXPERIMENTAL
Intervention: NAB 365 (clenbuterol-HCl) 24 micrograms, 3 times daily for 7 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fenoterol HBr 5 mg, 3 times daily for 7 days
Number of subjects: 30
Study: 29748736

Group type: EXPERIMENTAL
Intervention: Extended 24-week Social Skills Group Training (SSGT) program KONTAKT
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study: 27631775

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SC) - 5×5 Gy in 1 week, early surgery, and 6 courses of adjuvant chemotherapy.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-course chemoradiotherapy (LC) - 50.4 Gy in 28 fractions over 5.5 weeks with infusion of 5-fluorouracil, surgery in 4 to 6 weeks, and 4 courses of chemotherapy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-course chemoradiotherapy (LC)
Number of subjects: 0
Study: 26437027

Group type: COMPARATOR
Intervention: Magnetic sphincter augmentation device (MSAD)
Number of subjects: 44
Study: 23712056

Group type: EXPERIMENTAL
Intervention: Test of Infant Motor Performance (TIMP)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Alberta Infant Motor Scale (AIMS)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: AIMS at 6 months CA
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Parental-reported walking age
Number of subjects: 95
Study: 21220339

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19762662

Group type: EXPERIMENTAL
Intervention: HIV-prevention group intervention
Number of subjects: 1047

Group type: COMPARATOR
Intervention: Individual-care and attention-matched controls
Number of subjects: 1047
Study: 17563166

Group type: EXPERIMENTAL
Intervention: Drinking moderation training with intervention enhancements (life skills training and booster sessions)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Drinking moderation training
Number of subjects: 144
Study: 15459218

Group type: EXPERIMENTAL
Intervention: PRT + TME
Number of subjects: 96

Group type: COMPARATOR
Intervention: TME alone
Number of subjects: 96
Study: 11437028

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 60 microg PGE1 over 2 hours during pedalergometry
Number of subjects: 10

Group type: COMPARATOR
Intervention: Historical control group (similar training program without PGE1)
Number of subjects: 10
Study: 9557427

Group type: EXPERIMENTAL
Intervention: Thiamine (25 mg/day) and Pyridoxine (50 mg/day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Thiamine (1 mg/day) and Pyridoxine (1 mg/day)
Number of subjects: 200
Study: 8345047

Group type: EXPERIMENTAL
Intervention: Nal-Glu plus T (100 micrograms/kg.day sc plus T enanthate, 200 mg im weekly)
Number of subjects: 19

Group type: COMPARATOR
Intervention: T alone (placebo sc injections daily plus T enanthate, 200 mg im weekly)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups (Nal-Glu plus T and T alone)
Number of subjects: 19
Study: 3725517

Group type: EXPERIMENTAL
Intervention: Monthly booster sessions after training
Number of subjects: 28

Group type: COMPARATOR
Intervention: No booster sessions after training
Number of subjects: 28
Study: 30476007

Group type: EXPERIMENTAL
Intervention: Combined behavioral and biomedical intervention
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Referral of sexual partners by passive referral
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis of index-partner pairs
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Demographic analysis of dyads
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Behavioral analysis of index participants
Number of subjects: 46
Study: 30322392

Group type: EXPERIMENTAL
Intervention: Low calorie diet (LCD)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Weight maintenance diet (control)
Number of subjects: 97
Study: 27010809

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose before PPCI, followed by 90 mg twice daily for 1 year)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose before PPCI, followed by 75 mg once daily for 1 year)
Number of subjects: 400
Study: 24993911

Group type: EXPERIMENTAL
Intervention: Intensive intervention (additional visits, telephone calls, education)
Number of subjects: 3100

Group type: COMPARATOR
Intervention: Standard intervention (usual follow-up care)
Number of subjects: 3100
Study: 22732382

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium cream 4%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19932545

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Home-based exercise training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 70
Study: 17368650

Group type: EXPERIMENTAL
Intervention: Single circuit-resistance training (10 exercises at 35% of 1RM)
Number of subjects: 20
Study: 15922820

Group type: EXPERIMENTAL
Intervention: Nizatidine oral solution (2.5 mg/kg or 5 mg/kg BID)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Nizatidine extemporaneous solution (2.5 mg/kg or 5 mg/kg BID)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Nizatidine capsules (150 mg BID for ages 13-18)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Nizatidine (all formulations)
Number of subjects: 210
Study: 12876092

Group type: EXPERIMENTAL
Intervention: Significant results (P<=0.05)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Nonsignificant results (P>0.05 or not reported)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Oral or plenary presentation
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Pharmaceutical sponsorship
Number of subjects: 510
Study: 11128879

Group type: EXPERIMENTAL
Intervention: Consumption of 7 or more portions of fresh vegetables per week
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dietary habits (portions of fish, chicken, fruits, milk, and potatoes consumed each week)
Number of subjects: 112
Study: 8775399

Group type: EXPERIMENTAL
Intervention: Hyoscine hydrobromide (300 micrograms)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 1442614

Group type: EXPERIMENTAL
Intervention: Low-dose dofetilide (3 micrograms/kg loading dose over 15 minutes and 1.5 micrograms/kg maintenance dose over 45 minutes)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-dose dofetilide (6 + 3 micrograms/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6727750

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 28
Study: 3522159

Group type: EXPERIMENTAL
Intervention: Piretanide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31916830

Group type: EXPERIMENTAL
Intervention: Sans Forgetica font
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control font (not specified)
Number of subjects: 160
Study: 31680621

Group type: EXPERIMENTAL
Intervention: Intramuscular interferon β‐1a
Number of subjects: 235
Study: 30727881

Group type: EXPERIMENTAL
Intervention: 50 mg non-labeled ACT-541468 with 250 nCi of 14C-labeled ACT-541468
Number of subjects: 6
Study: 28954840

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate, High-Fiber, Low-Fat Diet
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Metformin (MET)
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Intensive Lifestyle Intervention (ILS)
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Placebo (PLBO)
Number of subjects: 3234
Study: 25985726

Group type: EXPERIMENTAL
Intervention: Dysregulated circulating miRNAs in symptomatic heart failure patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: miR-182, miR-200a*, miR-568
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: miR-155, miR-595
Number of subjects: 42
Study: 23197844

Group type: EXPERIMENTAL
Intervention: Patient-centered counseling intervention
Number of subjects: 355

Group type: COMPARATOR
Intervention: Attention control (AC) condition
Number of subjects: 355
Study: 21233091

Group type: EXPERIMENTAL
Intervention: 6-inch sleeping-head-up (SHU) for 6 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard non-pharmacological measures)
Number of subjects: 100
Study: 18070245

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg/d
Number of subjects: 627

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 627
Study: 17130328

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg x kg(‐1)) before and after cardiopulmonary bypass
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no steroid administration)
Number of subjects: 60
Study: 12480972

Group type: EXPERIMENTAL
Intervention: Subcutaneous erythropoietin (Epo) given every 1-3 weeks to maintain hemoglobin at 12.5 g% and intravenous iron (Fe) as necessary.
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Subcutaneous erythropoietin (Epo) and intravenous iron (Fe) treatment.
Number of subjects: 179
Study: 11054618

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No ICD therapy
Number of subjects: 0
Study: 9372462

Group type: EXPERIMENTAL
Intervention: Contacts with stabilizing tendencies
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Contacts with unstabilizing tendencies
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Contacts with mechanically unstabilizing effects
Number of subjects: 38
Study: 1609038

Group type: EXPERIMENTAL
Intervention: Gepirone at a mean dose of 16.25 mg/day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 3928422

Group type: EXPERIMENTAL
Intervention: Intravenous and intraduodenal amino acid infusion
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intrajejunal amino acid infusion
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intrajejunal hyperosmolar mannitol (850 mosmol/kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intrajejunal balloon distention (40 mmHg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Serum gastrin levels
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Plasma amino acids
Number of subjects: 16
Study: 31915146

Group type: EXPERIMENTAL
Intervention: Physical activity (MET-hours/week of moderate-to-vigorous physical activity)
Number of subjects: 9886

Group type: EXPERIMENTAL
Intervention: Diet quality (Healthy Eating Index - HEI-2015 score)
Number of subjects: 9886

Group type: EXPERIMENTAL
Intervention: Combination of physical activity and diet quality
Number of subjects: 9886

Group type: EXPERIMENTAL
Intervention: Physical activity, diet quality, and their combination
Number of subjects: 9886
Study: 30205315

Group type: EXPERIMENTAL
Intervention: Chlorella supplementation (1500 mg/day for 8 weeks)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Chlorella supplementation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 44
Study: 25963932

Group type: EXPERIMENTAL
Intervention: Transcutaneous Vagus Nerve Stimulation (tVNS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham tVNS (stVNS)
Number of subjects: 49
Study: 24071616

Group type: EXPERIMENTAL
Intervention: PVBs and propofol-based total intravenous anesthesia
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standardized general anesthesia (control group)
Number of subjects: 66
Study: 22725946

Group type: EXPERIMENTAL
Intervention: Micafungin
Number of subjects: 65

Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 65
Study: 20199550

Group type: EXPERIMENTAL
Intervention: Moisturizer application after repeated hand washing (5 different moisturizers)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Moisturizer application (3 of the 5 products)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Soap alone (control group)
Number of subjects: 132
Study: 18621090

Group type: EXPERIMENTAL
Intervention: BioDis method for drug release prediction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel pH- and time-based multi-unit formulations
Number of subjects: 0
Study: 15763286

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (age matched healthy controls)
Number of subjects: 27
Study: 14594516

Group type: EXPERIMENTAL
Intervention: TTS-fentanyl (25 microg/h for 3 days, then titrated)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Sustained-release oral morphine (30 mg every 12 h, then titrated)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: TTS-fentanyl
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 131
Study: 11329100

Group type: EXPERIMENTAL
Intervention: 7 days of antibiotic therapy (2 days of cefuroxime 750 mg IV every 8 hours followed by 5 days of cefuroxime axetil 500 mg orally every 12 hours)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 10 days of antibiotic therapy (2 days of cefuroxime 750 mg IV every 8 hours followed by 8 days of cefuroxime axetil 500 mg orally every 12 hours)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 52
Study: 7772359

Group type: EXPERIMENTAL
Intervention: lidocaine 1.5 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: esmolol 1.4 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: nitroglycerin 2 micrograms/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: saline 5 ml
Number of subjects: 40
Study: 2127787

Group type: EXPERIMENTAL
Intervention: 1 million units of interferon alfa-2b, subcutaneously thrice weekly for 6 months
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 million units of interferon alfa-2b, subcutaneously thrice weekly for 6 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 million units of interferon alfa-2b, after initial 24 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1 million units of interferon alfa-2b, after initial 24 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 million units of interferon alfa-2b
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1 million units of interferon alfa-2b
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients
Number of subjects: 80
Study: 758627

Group type: EXPERIMENTAL
Intervention: Time constant of 0.1 sec
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Time constant of 0.3 sec
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Time constant of 1.0 sec
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Time constant of 10.0 sec
Number of subjects: 1
Study: 31831295

Group type: EXPERIMENTAL
Intervention: Prostatic artery embolisation (PAE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 80
Study: 30832619

Group type: EXPERIMENTAL
Intervention: ET@Home education intervention (brochures, postcards, DVDs, and text messages over six months)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: KPSC standard of care education
Number of subjects: 1200
Study: 30388112

Group type: EXPERIMENTAL
Intervention: Orally administered lyophilized fecal microbiota product (n = 31)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Frozen fecal microbiota product by enema (n = 34)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both products (lyophilized and frozen)
Number of subjects: 65
Study: 27801415

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard wound care
Number of subjects: 42
Study: 24756362

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 11.25 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 30 mg
Number of subjects: 42
Study: 23255643

Group type: EXPERIMENTAL
Intervention: Measured resection technique (n=26)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Gap balancing technique (n=26)
Number of subjects: 52
Study: 20640511

Group type: EXPERIMENTAL
Intervention: Over-the-counter sales of antibiotics
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Injection antibiotics
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Combination of penicillins including β-lactamase inhibitors
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Penicillins with extended spectrum
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Second generation cephalosporins
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Respiratory conditions
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Demographic and socioeconomic factors
Number of subjects: 510
Study: 17998490

Group type: EXPERIMENTAL
Intervention: Beta carotene (50 mg, alternate days)
Number of subjects: 5956

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5956
Study: 14694248

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 12243918

Group type: EXPERIMENTAL
Intervention: 3 days of oral amoxicillin
Number of subjects: 2000

Group type: COMPARATOR
Intervention: 5 days of oral amoxicillin
Number of subjects: 2000
Study: 9704770

Group type: EXPERIMENTAL
Intervention: Preeclampsia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gestational Hypertension
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normotensive Controls
Number of subjects: 0
Study: 7991041

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 3288258

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin 100 MRCU/day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 49
Study: 31112641

Group type: EXPERIMENTAL
Intervention: Midazolam (M; 6 mg/kg IM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Midazolam-butorphanol (MB; 3 mg/kg each IM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no sedation)
Number of subjects: 12
Study: 26125538

Group type: EXPERIMENTAL
Intervention: Armodafinil (up to 150 mg/d for 4 weeks)
Number of subjects: 29
Study: 24812897

Group type: EXPERIMENTAL
Intervention: Xifeng Zhidong Tablet (XZT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 22693734

Group type: EXPERIMENTAL
Intervention: High-intensity white phototherapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: High-intensity yellow phototherapy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard pharmacotherapy
Number of subjects: 101
Study: 20075148

Group type: EXPERIMENTAL
Intervention: Treadmill training and orthoses
Number of subjects: 17

Group type: COMPARATOR
Intervention: Treadmill training
Number of subjects: 17
Study: 18616861

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 128
Study: 15569877

Group type: COMPARATOR
Intervention: Dipyridamole
Number of subjects: 11459

Group type: COMPARATOR
Intervention: Aspirin and dipyridamole
Number of subjects: 11459

Group type: COMPARATOR
Intervention: Control
Number of subjects: 11459
Study: 11890966

Group type: EXPERIMENTAL
Intervention: MSLT following PSG (MSLT-P)
Number of subjects: 20

Group type: COMPARATOR
Intervention: MSLT without prior PSG (MSLT-N)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Monotonous vigilance task (VT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale (ESS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scales (VAS)
Number of subjects: 20
Study: 8629589

Group type: EXPERIMENTAL
Intervention: Combined alpha-beta blockade (doxazosin 4 mg/day plus metoprolol 6.25 mg, gradually increased to 50 mg twice daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metoprolol alone (6.25 mg, gradually increased to 50 mg twice daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined alpha-beta blockade (doxazosin plus metoprolol)
Number of subjects: 30
Study: 2123759

Group type: EXPERIMENTAL
Intervention: Ovarian electrocautery
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Human menopausal gonadotrophins (hMG)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Pure follicle stimulating hormone (FSH)
Number of subjects: 88
Study: 6769450

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (SAB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 100
Study: 31554765

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1578